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Summary: If different analytical methods are alternatively used for the determination of the same analyte,
basic differences in test methodology can give rise to an increased number of deviating results. Such coexistence
of methods might be necessary, for example, during a transition phase while upgrading to new technologies.
We have exemplarily investigated this topic for the comparison of solid phase chemistry ("dry chemistry")
versus conventional methods ("wet chemistry"). The Kodak Ektachem 700XR clinical chemistry analyser was
compared with the Hitachi 737 analyser from Boehringer Mannheim using 18 clinical chemical analytes and
specimens submitted for routine analysis. Before the Start of the evaluation, the Ektachem 700XR was adjusted
("calibrated") by the manufacturer for optimal agreement with the Hitachi 737.
Satisfactory agreement was obtained for most investigated analytes äs judged by correlation coefficients and
three commonly applied regression methods (linear regression, principal components, and PassingjBablok
method). For some analytes, however, strongly deviating results were often obtained. Quality control-derived
limits (maximum acceptable inaccuracy) and data from biological Variation (critical differences) were used
for the assessment of the inter-instrument bias for diagnosis and patient monitoring, respectively. For enzymes,
0% (amylase) to 22% (creatine kinase) of all pathologic results differed by more than the maximum acceptable
analyticaj inaccuracy (21% —27%) of these analytes. If more stringent limits derived from biological Variation
were used, 24% (creatine kinase) — 62% (aspärtate aminotransferase) of all differences between paired
measurements exceeded the critical difference for enzymes. Deviations greater than the critical differences
were also marked for serum concentrations of sodium, calcium, and creatinine.
We conclude that the simultaneous use of analysers based on different analytical methodologies, i. e. solid
state chemistry and conventional methods, is generally problematic, especially for purposes of patient
monitoring.
in ction Early Instrumentation was focussed on small devices
Analysis using carrier=bound reägents ("solid phase for bedside analysis or testing in the Consulting room,
chemistry", "dry chemistry") is an evolvirig technique, but analysers for the large clinical laboratory are also
rapidly gaining acceptance in several areas of clinical available. It can therefore be anticipated that dry
chemistry (l — 3). Advantages over conventional anal- chemistry technology and traditional wet chemistry
ysis using liquid reägents ("wet chemistry") are methods will — at least during a transition phase -
(among others) high stability of reagents and calibra- coexist. This coexistence will occur between labora-
tion curves, rapid analysis, and the easy Operation of tories, i. e. some laboratories having integrated dry
analytical devices (4). chemistry analyzers, while others use conventional
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chemistry alone, and also within single laboratories.
This is because economy dictates the continuous use
of functionally still reliable equipment, while Invest-
ments in new Instruments eventually will favour dry
chemistry-based devices. In the present paper, we wish
to concentrate on the latter aspect. The central ques-
tion can thus be formulated äs:
What are the consequences (regarding the medical
Interpretation of laboratory results) if analytical
results are determined (probably within short in-
tervals between determinations) sometimes using
solid phase chemistry and sometimes using conven-
tional chemistry?
We have not investigated this topic in its füll gener-
ality, but have taken an exemplary, pragmatic ap^
proach by considering two devices, the Hitachi 737
and the Kodak Ektachem 700XR, which we think
can serve äs representative models for the study of
their intrinsic analytical techniques. We have further
reduced generality by focussing on analytical princi-
ples adapfed for German laboratories, which differ,
for example, from the respective procedures used in
the United States.
One can expect to observe discrepancies caused by
different sensitivities to interferences like drugs, or
properties of the specimen like viscosity (5). The con-
version of enzyme activities from 37 °C (Ektachem
700XR) to 25 °C (Hitachi 737) and different reaction
conditions (e. g. buffers) will lead to biased results, if
the temperature response is non-linear or if isoenzyme
patterns vary (6, 7).
This study is not concerned with the establishment of
ranks between the two analytical methodologies or
the two Instruments used äs representatives for these
methodologies. We have not attempted to evaluate
the "true" value of two diverging results by use of,
e. g., a definitive or reference method, but have re-
stricted our investigation to reporting the magnitude
and frequency of differences found for samples from
the daily routine analysis in our laboratory. The re-
ported figures are intended to serve äs a guideline for
the discrepancies one has to expect, if solid phase
chemistry and conventional chemistry are applied si-
multaneously.
Both Hitachi analysers were calibrated daily before Start of
routine analysis.
The Ektachem was calibrated once and adjusted for optimal
agreement with the Hitachi 737 by the manufacturer toefore the
start of the evaluation. During an initial phase both Instruments
were operated in parallel. Adjustment was made by two point
factorization of the Ektachem 700XR based on linear regression
of the collected data. Approximately 80 — 100 paired samples
were utilized for the regression of each analyte. Strongly de-
viating results ("outliers") were ornitted from the coniputations.
As stated by the manufacturer, the calibration was reliable for
all analytes during the whole evaluation period.
Analytical imprecisipn was determined by analysis of appro-
priate control materials after every tenth sample. For the Ek-
tachem 700XR two serum pools were used, while Kontrollogen
LU (Behringwerke AG, Frankfurt, Germany) was used for the
Hitachi 737. Accuracy was monitored with Kodatrol I or Ko-
datrol II (Kodak) for the Ektachem 700XR, and with Monitrol
I (Baxter Deutschland GmbH, Unterschleißheim, Germany)
and Kontrollogen LP (Behringwerke) contrpl sera for the Hi-
tachi analysers. j
Analytes
Visually normal samples from sera submitted for routine anal-
ysis were used for all comparisons. Measurements were per-
formed in batches consisting of « 20 specimen on both ana-
lysers on consecutive days at the same time. The results from
both analysers were conapared immediately, and if judged nee-
essary, the measurement was repeated to exclude outliers caused
by severe instrumental malfunction or sample mix up. Because
all suspect results were conflrmed within reasonable limits by
the respective analyser, we generally used the values of the first
determination for further investigations. This argument was not
välid for turbidimetric lipase analysis with the Hitachi 737. The
high frequency (8.5%) of obviously false, negative enzyme
activities (8, 9) caused us to omit this analyte from further
evaluation. A total of 18 different clinical chemical analytes
was investigated. Apart from their principally different analyt-
ical basis, different chemical methods are used for some analytes
by the Hitachi 737 and the Ektachem 700XR:
Enzyme activities are meäsürfcd at 25 °C by the Hitachi 737
according to modified recommendations of the Deutsche Ge-
sellschaft für Klinische Chemie, while the Ektachem 700XR
perfcrms these measurements at 37 °C according to IFCC
guidelines. Moreover, alanine aminotransferase1) and aspartate
aminotransferase1) are determined in presence of pyridoxal 5-
phosphate, while this additive is missing in the corresponding
methods of the Hitachi 737. Sodium and potassium are deter-
mined potentiometrically with ion-sensitive electrodes by both
Instruments, but a dilution of the sample is used by the Hitachi
737, while the Ektachem 700XR measures the undüuted sample
directly. Further differences (Ektachem 700XR / Hitachi 737)
exist with respect to enzyme Substrates (amylase: dyed starch /
/7-nitrophenylmaltoheptaoside, -glutamyltransferase1): *- -
glutamyl-3-carboxy-/?-nitroanilide / Z,-y-glutamyl-/?-nitroani-
lide), the determination of glucose (glucose oxidase / hexoki-
nase), creatinine (creatinine amidohydrolase / Jaffe), and cal-
cium (arsenazo III / o-cresolphtalein).
Methods
Devices
A Hitachi 737 analyser (Boehringer Mannheim, Mannheim,
Germany) which is used for routine analysis in our laboratory
was compared with a Kodak Ektachem 700 XR analyser (Ko-
dak AG, Stuttgart, Germany). For coraparison between two
conventional analytical methods the results of the Hitachi 737
were compared with those obtained by a Hitachi 717 analyser.
Statistical methods
The statistical methods Passing & Bablok (10, H), linear
regression (12), and principal component analysis (13), respec-
!) Enzymes: alanine aminptransferase (EC 2.6.1.2); alkaline
phosphiatase (EC 3.1.3.1); aspartate aminotransferase (EC
2.6.1.1); -glutainyltransferase (EC 2.3.2.2); lactate dehydro-
genase(EC 1.1.1.27)
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tively, were applied for method cornparison for all investigated
analytes.
For the assessment of deviations we computed the frequencies
of relative differences dt between values obtained from the same
sample x{ by both analysers:
x" — x?
were H denotes Hitachi 737 and K Kodak Ektachem 700XR.
As discussed below, clipped ranges of deviations were used in
some instances.
For computations the Software packages Statgraphics (STCS
Inc., Rockville, MD), SAS (SAS Institute Inc., Cary, USA),
and Methoden vergleich (Boehringer) were used.
Results
Method comparisons
The between-run itnprecisions of both Instruments
during the evaluation are given in table 1. The results
of the method comparisons are shown in table 2 and
exemplarily for serum creatinine in fig re 1. Except
for sodium and calcium, the coefficients of correlation
are close to 1. Approximately the same slopes and
intercepts were obtained by the three statistical meth-
ods. Differences in the tests for significance emerge
s a consequence of the different assumptions of the
respective statistics.
Tab. 1. Between-run analytical imprecisions for the Ektachem 700XR and the Hitachi 737. Two serum pools with pathological
(high) and normal (low) concentrations (given in parenthesis) were used for the Ektachem 700XR.
Analyte Ektachem 700XR
CV [%]
Hitachi 737
CV [%]
Low High Low High
Sodium [nunol/1]
Potassium [mmol/1]
Calcium [mmol/1]
Glucose [mmol/1]
Creatinine [μιηοΐ/ΐ]
Protein [g/l]
Urea [mmol/1]
Triacylglycerols [ramol/l]
Bilirubin [μηιοΐ/ΐ]
Cholesterol [mmol/1]
Uric acid [μηιοΐ/ΐ]
Amylase [U/l]
Aspartate aminotransferase
Lactate dehydrogenase
Alkaline phosphatase
γ-Glutamyltransferase
Creatine kinase
Alanine aminotransferase
1.2 (143)
1.2 (4.16)
1.7 (2.47)
0.9 (5.94)
4.7 (71)
1.9 (76)
1.5 (4.83)
1.2 (1.39)
0.0 (8.55)
1.8 (5.65)
1.1 (244)
1.9 (57)
10.8 (9)
3.5 (121)
2.8 (102)
4.1 (12)
2.0 (49)
6.8 (7.5)
1.5 (148)
1.1 (5.0)
1.3 (2.38)
1.3 (8.16)
0.9 (539)
2.1 (66)
1.0 (22.3)
1.6 (4.42)
1.4 (75.2)
1.1 (5.46)
1.3 (488)
1.5 (178)
0.5 (250)
2.1 (729)
1.9 (569)
1.6 (253)
1.2 (296)
0.5 (110)
1.2 (138)
1.2 (4.24)
4.0 (2.25)
4.2 (4.05)
4.2 (106)
2.0 (65)
3.3 (5.16)
1.7 (1.07)
3.2 (18.8)
3.1 (4.92)
2.5 (303)
3.4 (60)
3.1 (34)
3.2 (222)
8.7 (76)
5.7 (16)
3.3 (51)
2.5 (26)
1.8 (168)
1 .7 (6.29)
2.4 (3.2)
1.9 (13.5)
2.2 (293)
2.5 (58)
3.2 (16.2)
2.8 (1.15)
1.6 (44.5)
4.3 (3.06)
3.5 (521)
2.7 (244)
2.4 (85)
5.3 (419)
4.8 (430)
5.9 (115)
2.7 (196)
3.2 (87)
Tab. 2. Method cornparison between Ektachem 700XR and Hitachi 737. Results of the regression procedures are given s slope
± intercept.
Analyte
Sodium
Potassium
Calcium
Glucose
Creatimne
Protein
Urea
Triacylglycerols
Bilirubin
Cholesterol
Uric acid
Amylase
Aspartate aminotransferase
Lactate dehydrogenase
Alkaline phosphatase
γ-Glutamyltransferase
Creatine kinase
Alanine aminotransferase
N
168
174
188
167
189
190
1-85
179
201
160
160
118
168
196
212
172
81
168
r
(Pearson)
0.874
0.975
0.887
0,997
0.996
0.975
0.998
0.984
0.995
0.986
0.983
0.993
0.995
0.981
0.986
0.993
0.999
0.995
Linear
regression
0.775a+
0.989 -
0.999 -
1.033 -
0.932 +
0.912 +
0.907 -l·
0.949 +
1.108 -
0.916 +
0.909 +
0.975 +
0.961 +
0.874 +
0.967 -
0.998 -
0.979 -
0.961 +
32.9
0.01
0.09
0.40
1.94
7.31
0.14
0.05
2.17
0.31
13.7
5.33
3.58
4.51
10.1
5.17
8.87
3.58
Passingl Bablok
0.857 +
1.000 +
1.111 -
1.033 -
0.901 +
0.925 +
0.889 +
0.948 +
1.000 ±
0.919 +
0.963 +
1.063 -
0.996 +
0.886 -
0.929 -
1.011 -
0.900 +
0.996 +
21.7
0.00
0.36
0.40
5.22
6.48
0.29
0.04
0.00
0.30
3.39
2.22
2.15
0.12
3.40
5.42
0.30
2.15
Principal
components
0.887 +
1.014 -
1.127 -
1.037 -
0.936 +
0.935 +
0.909 +
0.964 +
1.114 -
0.929 +
0.924 +
0.982 +
0.966 +
0.891 -
0.980 -
1.005 -
0.981 -
0.966 +
17.3
0.12
0.40
0.43
1.41
5.70
0.12
0.02
2.33
0.24
8.98
4.62
3.37
1.04
13.1
5.68
9.12
3.37
Boldface: significant difference (p < 0.05) of slope or intercept from 1.0 or 0.0, respectively
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Fig. l. Linear regression of the analysis of serum creatinine by
the Hitachi 737 versus Ektachem 700XR. Regression
data are given in table 2.
Significant deviations with respect to slope or inter-
cept werfe öbserved for most analytes (especially strikt
ing: sodium, aspartate aminotransferase and lactate
dehydrogenase). Our results are, however, comparable
to those published by others (3, 14), who judge overall
conformity to be satisfactory.
Frequencies of discrepant results
Inter-instrument bias related to analytical inaccuracy
Desirable goals for analytical errors have been related
to biological Variation (15). According to Tonk's rule
(16), for example, the allowable limits of error should
not exceed !/4 of the reference interval. These concepts
have been applied to analytical inaccuracy by Stamm
(17) and have recently been adopted äs criteria for
the establishment of tolerance limits in intra-labora-
tory quality control in German laboratories (18). In
short, the maximum acceptable percental inaccuracy
is three times the maximum coefficient of Variation
(CV) from day to day which is defined by % of the
respective reference ränge. For sodium, e. g., with a
reference interval of 135-144 mmol/1, this gives:
144 - 135
- 4- = 2.25 mmol/1.
As a percentage of the reference ränge (with some
rounding off) the maximum CV is computed äs:
100
Further, the maximal percent inaccuracy of a single
result is three times this maximal CV, which in the
case of sodium will give 6%.
This inaccuracy can be interpreted äs the maximum
deviation from the true value the clinician has to take
into account ifshe/he compares patient results with the
reference ränge ofthe analyte. The application of these
limits äs cut-off values for the assessment of deviating
results is aimed at demonstrating the number of ex-
cessively high differences wliich can lead to ipossibly
wrong diagnostic decisions.
Because our primary interest is in diagnostically rel-
evant inter-instrumental bias, only determinations
with at least one of both results beyond the reference
interval (sodium, potassium, calcium, glucose, pro-
tein) or above the upper reference limit (enzymes,
creatinine, urea, triacylglycerols, bilirubin, choles-
terol, uric acid) of the respective analyte were consid-
ered for the computation of the frequencies of differ-
ences. Unfortunately, for some analytes (potassium,
calcium, protein, creatine kinase), there was only a
small number of pathological results, thereby lowering
the accuracy of the respective frequencies.
Table 3 shows the relative frequencies of differences
between paired measuremerits which exceed the qual-
ity control-derived limits. For most metabolites and
electrolytes these frequencies are small. However, for
potassium, protein, and most enzymes considerably
high frequencies (up to 22% of all investigated sarn-
ples) were found.
As shown exerhplarily in figures 2a—d for some an-
alytes, these differences were not distributed perfectly
symmetrically with respect to zero. This might be
explained by a systemätic offset of one Instrument.
We have not corrected for such bias, using e. g. linear
regression, because
(i) both analysers had been adjüsted optimally be-
fore start of the evaluation,
(ii) the calibration ofthe Ektachem was stable during
the whole evaluation phase, and
(iii) the day-to-day imprecision of both analysers was
also satisfactorily during this phase.
The eliminatiön of systemätic and proportional bias
by use of linear regression would of eourse have
decreased the frequencies of deviating results, but
using the evaluation-data themselves for such "re-
calibration" woüld prodüce both over-optimistie and
unrealistic results. Under routine conditions it wöuld
make no sense to perform all measurements on both
analysers. On the other hand, if only some samples
were randomly selected for the adjustment, the results
of just these samples migfet by Chance be strongly
divergent, leading to even worse overall perfofmance.
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Tab. 3. Comparison of Ektachcm 700XR vs Hitachi 737. Relative frcquencics of diflcrcnccs beyond tolerancc limits arc givcn
for the inaccuracy critcrion and the critical diffcrcncc criterion.
Analyte Relevant for diagnosis
Inaccuracy Rcference
criterion* rangeb
Sodium
Potassium
Calcium
Glucosc
Crcati n ine
Protein
Urea
Triacylglycerols
Bilirubin
Cholcstcrol
Uric acid
Amylase
Asparlale aminotransferase
Lactatc dchydrogcnasc
Alkaline phosphatasc
-Glutamyltransfcrasc
Creatine kinase
Alanine aminotransferase
0.06
O.OB
o.to
0.15
0.18
0.09
0.24
0.21
0.21
0.18
0.18
0.27
0.21
0.21
0.21
0.21
0.24
0.21
135 -144 (50)
3.6- 5.1 (15)
2.2- 2.6 (44)
3.9- 6.1 (69)
<106 (50)
66 - 83 (74)
< 7.65 (76)
< 2.28 (55)
< 3.4 (60)
< 6.47 (51)
<416 (26)
<130 (24)
< 17 (83)
<240 (106)
<190 (73)
< 28 (103)
< 80 (9)
< 23 (71)
Frcquency
0
0.13
0.07
0
0.06
0.07
0
0
0.05
0
0
0
0.15
0.06
0.12
0.04
0.22
0.14
Relevant for
Crilical
diffcrcnccc
0.02
0.13
0.05
0.38
0.10
0.07
0.14
0.40
0.38
0.08
0.15
0.12
0.13
0.14
0.08
0.16
0.23
0.15
monitoring
Frequcncy
0.49
0
0.33
0
0.43
0.14
0.04
0
0.02
0.15
0.02
0.27
0.62
0.28
0.59
0.54
0.24
0.48
a
 Maximal allovvablc relative devialion for analytical inaccuracy according to the quality conlrol guidelines for German labora-
torics
b
 Number of cases outside the rcfercnce ränge are given in parenthesis
c
 Change in serial results from the samc patienl nccessary for statistical significance (P < 0.05)
0.30
0.25 -
k
 0.20 -
0.15 -
0.10 -
0.05 -
-0.5 -0.3 -0.1 0.1 0.3
Fractions of differences
0.1 0 0.1
Fractions of differences
0.30
0.25
0.15
0.10
0.05
n
\
0.3
' 0.2
0.1
J_
\
-1.0 -0.6 -0.2 0 0.2Fractions of differences
0.4 0.6
-0.2 0.2 0.6 1.0 ~ -°-6 ~° ·
Fractions of differences
Fig 2 Frequency distributions of differences between results from Hitachi 737 and Ektachem 700XR. Only pathological values
were considered. The dotted lines indicate the maximirai acceptable inaccuracy limits. a: Creatinine, b: Glucose, c:
Aspartate aminotransferase, d: Alanine aminotransferase.
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Inter-instrument blas related to critical differences
The concept of the critical difference can be used to
follow the course of laboratory parameters in one
individual in consecutive measurements (19). The crit-
ical difference dK is dependent on the intra-individual
variance of serial measurements in one individual and
is given with p < 0.05 by dK = 2.8 }/sf + & where
Si and sa are the intra-individual and analytical vari-
ances, respectively. For duplicate measurements of
the same sample the intra-individual component of
dK is zero and any difference between determinations
is due to the analytical variance only. As a conserv-
ative criterion we assume that the analytical variance
should not produce differences exceeding the critical
difference given by biological Variation alone, i. e. the
difference between measurements on both analysers
should be less than 2.8 st or 2.8 CVh if the coef-
ficient of Variation is used.
In table 3, the relative frequencies of differences >
the critical differences are shown for all investigated
analytes! Data on intra-individual variances during
one day were taken from Costongs et al. (19). Since
patient monitoring is not necessarily restricted to the
observation of pathological values, results within ref-
erence ranges were also considered in the computa-
tions.
With respect to the critical differences, the frequencies
of deviating results were generally higher than those
obtained using the inaccuracy criterion. For enzyme
activities they ränge from 0.24—0.64. Additionally,
the frequencies for sodium, calcium, and creatinine
(fig. 3) were much higher than those obtained using
the inaccuracy criterion (fig. 2a).
Inter-instrument differences between two conventional'
analysers
To investigate whether the reported discrepancies aje
due to the analytical itiethodölogy, we additionally
compared two Instruments employing identical meth-
ods. Restricted to five of therniost deviatiiig änälytes,
this evaluation was performed äs described above for
the comparison between Ektachem 700XR and Hi-
tachi 737. The results are given in table 4 and exem-
plarily for serum creatinine in figure 4a--b. With
respect to the inaccuracy criterionj there was high
conformity between the two Instruments. Much
higher figures were observed using the criterion of
critical differences. But, except for the analysis of
creatinine, these fractions were only about 50% of
those found for the formet comparison.
0.4
0.3
!0.2
0.1
-0.6 -0.4 -0.2 0 0.2
Fractions of differences
0.4 0.6
0.4
0.3
£ 0.2
S
0.1
-0.8
-0.4 0 0.4
Fractions of differences
0.8
Fig. 3. Frequency distribution of differences between creatinine
results from Hitachi 737 and Ektachem 700XR. All
values were considered. The dotted lines indicate the
limits defined by critical difference.
0.4
0.3
2 0.2
0.1
-0.8 -0.4 0 0.4
Fractions of differences
0.8
Fig. 4. Frequency distributions of dißferences between creati-
nine results from Hitachi 737 and Hitachi 717. The
dotted lines indicate the maximum acceptable inaccu-
racy limits (a) and limits defined by critical difference
(b), respectively.
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Discussion
This paper was initiated by experience of the intro-
duction of an analyser based on dry chemistry sheets
into our laboratory, which otherwise employed solely
conventional wet chemistry-based analysis. The plan
was to use a Kodak Ektachem 700XR in the emer-
gency laboratory in parallel with two Hitachi 737
machines for routine analysis.
After adjustment of the Ektachem 700XR to the
currently used analysers (see above), satisfactorily cor-
relation and regression data were found. The results
shown in table 2 are in agreement with the data found
by others (3,14). Also with respect to internal quality
control, both techniques give similar results, äs shown
in table 1. Fulfillment of these criteria is commonly
accepted for sufficient comparability between meth-
ods (20, 21). Nevertheless, during parallel use a not-
able number of discrepant results occurred which were
reproducible and thus could not be explained by
chance alone. This therefore raised the question of
the frequency of medically relevant differences (15)
caused by the coexistence of diverse analytical meth-
odologies.
In general, physicians request laboratory tests for two
reasons: to assist in diagnosis or to monitor patients
(22, 23). Because inter-instrument bias will have dif-
ferent effects in these two areas, we established two
sets of criteria for the assessment of excessive differ-
ences between both Instruments.
For diagnosis, analytical results should agree with
respect to decisions based on established reference
intervals. As described above, maximal tolerable in-
accuracy in German laboratories is defined by Mi of
the respective reference ranges (18). This criterion
could not be achieved for 10 out of 18 investigated
analytes (tab. 3). If foutinely applied for anlaysis the
outcome of this "inaccuracy" would lead to diverse
classifications of pathological arid normal cases. For
example, only 74 out of 84 sera with elevated aspartate
aminotransferase activities were classified äs patho-
logical by both methods (results not shown). Al-
though an attempt was made to adjust the Ektachem
700XR to the Hitachi 737 for optimal agreement of
the results, systematic bias was observed (fig. 2a-d).
Obviously, for some analytes the adjustment of the
Ektachem 700XR was performed incorrectly or at
least suboptimally by the manufacturer. For potas-
sium, creatinine, protein, and lactate dehydrogenase
a recalibration would have led to clearly decreased
frequencies of discrepant results, which should be
apparent from the respective figures in table 3. We
have, nevertheless, reported the frequencies obtained
during the original adjustment by the manufacturer,
because this procedure is generally performed during
Installation of the Ektachem 700XR and an extensive
evaluation followed by eventual recalibration might
not necessarily be undertaken by all laboratories.
For monitoring of patient laboratory results, differ-
ences between consecutive measurements can be as-
sessed by comparison with the intra-individual Vari-
ation of a given analyte (24, 25). We calculated the
frequencies of significant deviations according to the
concept of critical differences. Most analytes are ef-
fectively controlled by homeostatic mechanisms, lead-
ing to smaller fluctuations within one individual than
in population-based reference ranges. Therefore,
cleafly elevated frequencies of results exceeding the
critical difference criterion could be expected (tab. 3).
These frequencies are further increased by the fact
that normal results were considered in the calcula-
tions. It should be stressed, however, that under cer-
tain conditions patient monitoring within the refer-
ence ränge is necessary, e. g. glucose concentration in
diabetics, creatinine concentration after kidney trans-
plantation, or control of infusion therapy. For 6 an-
alytes more than 40% of all results differed by
amounts greater than the respective critical difference!
Found discrepancies can be explained at least in part
by differences in analytical methodology. Measure-
Tab.4. Comparison of Hitachi 717 vs Hitachi 737. Relative frequencies of differences beyond tolerance limits are given for the
inaccuracy criterion and the critical difference criterion.
Analyte
Creatinine
Aspartate aminotransferase
Alkaline phosphatase
Creatine kinase
Alanine aminotransferase
Inaccuracy
criterion3
0.18
0.21
0;21
0.24
0.21
Reference rangeb
106 (115)
17 (83)
190 (120)
80 (45)
23 (78)
Frequency
0.03
0
0
0
0
Critical
difference0
0.10
0.13
0.08
0.23
0.15
Frequency
0.37
0.33
0.26
0.15
0.17
a
 Maximal allpwable relative deviation for analytical inaccuracy according to the quality control guidelines for German labora-
tories
b
 Number of cases outside the reference ränge are given in parenthesis
c
 Change in serial results from the same patient necessary for statistical significanee (P <, 0.05)
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menl of enzyme activities at different temperatures is
cumbersome, since biased total activities will emerge
from differences in the temperature-dependence of
isoenzymes. In addition, Variation of Substrates or
cofactors, e. g. supplementation of the assay sample
with pyridoxal 5-phosphate (aspartate aminotrans-
ferase, alanine aminotransferase), can alter the out^
come of the analysis in certain patients (7, 26). Owing
to different sensitivity to interference, this is also true
if quite different methods are applied, e. g. Jaffe and
creatinine amidohydrolase in the analysis of creatinine
(27 — 30). Differences in the matrix effects on dry
chemistry sheets and in conventional analysis are well
known (3, 5, 7,14, 31, 32). Since most of these factors
show no systematic influence, a general correction by
"factorization" is impossible. This explains diverse
results in spite of optimal adjustment of the Instru-
ments by linear regression. Only if identical methods
are used can an optimal adaptation of Instruments be
expected, äs further demonstrated by the higher co-
incidence of the Hitachi 737 / Hitachi 717 results (tab.
4). At this point it must be stated clearly that by
observing frequencies of differences only, the evalu-
ated Instruments are treated symmetrically, i. e. we do
not blame one method for producing false results.
Depending on the respective analyte, one or the other
methodology might be advantageous. Judgement of
true results is only possible with respect to definitive
methods. Unfortunately, such methods are not avail-
able for all anaiytes and method comparisons are
performed with respect to nationally recommended
procedures. Therefore assessment of accuracy is only
possible with respeet to these procedures, and imple-
mentation of new technologies can only occur after
modification of the respective recommendations.
In conclusion we have shown that several problems
arise if different methodologies are used simultane-
ously in the same laboratöry, even if acceptable cor-
relation data exist. Since method-dependent bias
causes considerably divergent results, a simultaiieous
use of both Instruments should be carefülly organized.
For example, patient-dependent sample distribution
(same Instrument for all specimens of one patient)
might be appropriate. Another possibility would be
the distribution of the applied methods between in-
struments, e. g. sole use of the most converiient
method. Finally, an unselected use of both Instru-
ments combined with careful control and perhaps re-
measurement with the alternative Instrument seems
possible. But all these measures implicate an increase
in workload, costs, turnaround time, and chance of
mistakes.
References
1. Curme, H. G., Columbus, R. L., Dappen, G. M., Eder, T.
W., Fellows, W. D., Figueras, J., Glover, C. R, Goffe, C.
A., Hill, D. E., Lawton, W. H., Muka, E. J., Pinney, J. E.,
Rand, R. N., Sanford, K. J. & Wu, T. W. (1978) Multilayer
film elements for clinical analysis: General coneepts. Clin.
Chem. 24, 1335-1342.
2. Libeer, J. C. (1985) Solid phase chemistry in clinical labo-
ratöry tests: a literature review. J. Clin. Chem. Clin.
Biochera. 23, 645-655.
3. Sonntag, O. (1988) Trockenchemie. Analytik mit trägerge-
bundenen Reagenzien. Georg Thieme, Stuttgart - New
York.
4. Sandberg, S., Christensen, N. G., Thue, G. & Lund, R K.
(1989) Performance of dry-chemistry Instruments in pri-
mary health care. Scand. J. Clin. Lab. Invest. 49, 483-
488.
5. Eastep, S. J., Benson, R J., Preese, L. M. & Apple, F. S.
(1989) Factitiously high sodium activities on the Ektachem
400 owing to interferences by high gamma-globulin con-
centrations. Clin. Chem. 35, 333-334.
6. Hafkenscheid, J. C. M & van der Ven-Jongerkrijg, J. (1988)
Two dry-reagent Systems evaluated for determinations of
enzyme activities. Clin. Chem. 34, 155-157.
7. Wallinder, H., Angbäck, K., Kahan, J., Onica, D. & Wal-
denlind, L. (1989) Measurement of alkaline phosphatase
activity by Kodak Ektachem 700 XR analyzer compared
with other routine analytical methods. Clin. Chem 35
328-329. ' '
8. Weiß, T. & Lorentz, K. (1984) Vergleichende Lipasebestim-
mungen mit turbidimetrischer Technik und Enzymimmu-
noassay. Lab. Med. 8, 63—67.
9. Junge, W., Leybold, K. & Kraack, B. (1983) Influence of
colipase on the tufbidimetric detennination of pancreatic
lipase catalytic activity. J. Clin. Chem. Clin. Biochem. 27,
445-451.
10. Bablok, W. & Passing, H. (1983) A new biometrical pro-
cedure for testing the equality of measurements from two
different analytical methods. J. Clin. Chem. Clin. Biochem.
2l , 709-720.
11. Haeckel, R. & Passing, H. (1985) Statistische Probleme
beim Vergleich klinisch-chemischer Analysenverfahren. J.
Clin. Chem. Clin. Biochem. 23, 307-318.
12. Sachs, L. (1984) Angewandte Statistik: Anwendung stati-
stischer Methoden. 17tb Ed., Springer, Berlin.
13. Feldmann, U, Schneider, B. & Klinkers, H. (1981) A mul-
tivariate approach for the biometric comparison of analyt-
ical methods in clinical chemistry. J. Clin. Chem. Clin.
Biochem. 19, 121^137.
14. Kadinger, C. L. & O'Kell, R. T. (1983) Clinical evaluation
of Eastman Kodak's Ektachem 400 analyzer. Clin. Chem.
29,498-501.
15. Fräser, C. G. (1983) Desirable performance Standards for
clinical chemistry tests. Adv. Clin. Chem. 23, 299-339.
16. Tonks, D. B. (1963) A study of the accuraey and precision
of clinical chemistry determinations in 170 Canadian lab-
oratories. Clin. Chem. 9, 217-223.
17. Stamm, D. (1982) A new eoncept-for quality control of
clinical laboratöry irivestigation in the light of clinical re-
quirements and based upon reference method values. J.
Clin. Chem, Clin. Biochem. 20, 817—824.
»18. Stamm, D. (1988) Qualitätssicherung der quantitativen Be-
stimmungen im Laboratorium. Dt. Ärtzebl. 85, 697 — 712.
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 29, 1991 / No. 10
Kröpfet al.: Practical implications of coexistent differont technologies 683
19. Costongs, G. M. P. J., Janson, P. C. W., Bas, B. M.,
Hermans, J., van Wersch, J. W. J. & Brombacher, P. J.
(1985) Short-term and long-term intra-individual variations
and critical differences of clinical chemical laboratory pa-
rameters. J. Clin. Chem. Clin. Biochem. 23, 7 — 16.
20. Westgard, J. O. & Hunt, M. R. (1973) Use and Interpre-
tation of common statistical tests in method-comparison
studies. Clin. Chem. 19, 49—57.
21. Koch, D. D., Hassemer, D. J., Wiebe, D. A. & Laessig, R.
H. (1988) Testing cholesterol accuracy. J. Am. Med. Ass.
260, 2552-2557.
22. Harris, E. K. (1975) Some theory of reference values. I.
Stratified (categorized) normal ranges and a method for
following an individuaPs clinical laboratory values. Clin.
Chem. 27, 1457-1464.
23. Harris, E. K. (1976) Some theory of reference values. II.
Comparison of some statistical models of intraindividual
Variation in blood constituents. Clin. Chem. 22, 1343 —
1350.
24. Harris, E. K., Cooil, B. K., Shakarji, G. & Williams, G.
Z. (1980) On the use of statistical models of within-person
Variation in long-term studies of healthy individuals. Clin.
Chem. 26, 383-391.
25. Harris, E. K. & Yasaka, T. (1983) On the calculation of a
"reference change" for comparing two consecutive meas-
urements. Clin. Chem. 29, 25 — 30.
26. Gressner, A. M. & Sittel, D. (1985) Plasma pyridoxal 5'-
phosphate concentrations in relation to apo-aminotrans-
ferase levels in normal, uremic, and post-myocardial infarct
sera. J. Clin. Chem. Clin. Biochem. 23, 631-636.
27. Bissell, M. G., Ward, E., Sanghavi, P., Toffaletti, J., Bird,
C., Berg, C., Jerkunica, I. & Hutton, P. F. (1987) Multila-
boratory evaluation of the new, single-slide enzymatic cre-
atinine method on the Kodak Ektacbem analyzer. Ciin.
Chem. 33, 951.
28. Kroll, M. H., Roach, N. A., Poe, B. & Elin, R. J. (1987)
Mechanism of interference with the Jaffe reaction for cre-
atinine. Clin. Chem. 33, 1129-1132.
29. Roberts, R. T., Alexander, N. M. & Keiner, M. J. (1988)
Definitive liquid-chromatographic demonstration that n-
ethylglycine is the metabolite of lidocaine that interferes in
the Kodak sarcosine oxidase-coupled method for creati-
nine. Clin. Chem. 34, 2569-2572.
30. Apple, F. S., Benson, P., Abraham, P. A., Rosano, T. G. &
Halstenson, C. E. (1989) Assessment of renal function by
inulin clearance: comparison with creatinine clearance äs
determined by enzymatic methods. Clin. Chem. 35, 312 —
314.
31. Doumas, B. T., Hause, L. L., Simuncak, D. M. & Breiten-
feld, D. (1989) Differences between values for plasma and
serum in tests performed in the Ektachem 700 XR analyzer,
and evaluation of "Plasma Separator Tubes (PST)'\ Clin.
Chem. 35, 151-153.
32. Berg, J. D., Romano, G., Bayley, N. F. & Buckley, B. M.
(1988) Heparin interferes with aspartate aminotransferase
activity determination in the Ektachem 700. Clin. Chem.
34, 174.
Dr. J. Kröpf
Department of Clinical Chemistry
Philipps University
Baidingerstraße
W-3550 Marburg
Bundesrepublik Deutschland
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 29,1991 / No. 10

